Metabolic syndrome in adults with congenital heart disease

Journal of the American Heart Association

Volumn 5, Issue 2, 2016, Pages

  Deen, Jason F ^a,b   Krieger, Eric V ^a,b   Slee, April E ^a,c   Arslan, Alex ^c   Arterburn, David ^d   Stout, Karen K ^a,b   Portman, Michael A ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF WASHINGTON MEDICAL CENTER   (United States)

^c Axio Research   (United States)

^d GROUP HEALTH RESEARCH INSTITUTE   (United States)

Author keywords

Atherosclerosis; Congenital heart disease; Metabolic syndrome; Risk stratification

Indexed keywords

ADULT; AGED; ARTICLE; BODY MASS; CARDIOMETABOLIC RISK; CASE CONTROL STUDY; COHORT ANALYSIS; CONGENITAL HEART DISEASE; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; OBESITY; POPULATION RESEARCH; PRIORITY JOURNAL; RETROSPECTIVE STUDY; WASHINGTON; CHI SQUARE DISTRIBUTION; COMORBIDITY; HEART DEFECTS, CONGENITAL; MIDDLE AGED; ODDS RATIO; PREVALENCE; REGISTER; RISK ASSESSMENT; RISK FACTOR; STATISTICAL MODEL; YOUNG ADULT;

ADULT; CHI-SQUARE DISTRIBUTION; COMORBIDITY; FEMALE; HEART DEFECTS, CONGENITAL; HUMANS; LOGISTIC MODELS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; OBESITY; ODDS RATIO; PREVALENCE; REGISTRIES; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; WASHINGTON; YOUNG ADULT;

EID: 85002905940     PISSN: None     EISSN: 20479980     Source Type: Journal    
DOI: 10.1161/JAHA.114.001132     Document Type: Article

References (36)

1. O'Leary JM, Siddiqi OK, de Ferranti S, Landzberg MJ, Opotowsky AR. The changing demographics of congenital heart disease hospitalizations in the United States, 1998 through 2010. JAMA. 2013;309:984-986.
2. Verheugt CL, Uiterwaal CS, van der Velde ET, Meijboom FJ, Pieper PG, van Dijk AP, Vliegen HW, Grobbee DE, Mulder BJ. Mortality in adult congenital heart disease. Eur Heart J. 2010;31:1220-1229.
3. Giannakoulas G, Dimopoulos K, Engel R, Goktekin O, Kucukdurmaz Z, Vatankulu MA, Bedard E, Diller GP, Papaphylactou M, Francis DP, Di Mario C, Gatzoulis MA. Burden of coronary artery disease in adults with congenital heart disease and its relation to congenital and traditional heart risk factors. Am J Cardiol. 2009;103:1445-1450.
4. Reaven GM. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes. 1988;37:1595-1607.
5. Mottillo S, Filion KB, Genest J, Joseph L, Pilote L, Poirier P, Rinfret S, Schiffrin EL, Eisenberg MJ. The metabolic syndrome and cardiovascular risk a systematic review and meta-analysis. J Am Coll Cardiol. 2010;56:1113-1132.
6. Gami AS, Witt BJ, Howard DE, Erwin PJ, Gami LA, Somers VK, Montori VM. Metabolic syndrome and risk of incident cardiovascular events and death: a systematic review and meta-analysis of longitudinal studies. J Am Coll Cardiol. 2007;49:403-414.
7. Wilson PW, D'Agostino RB, Parise H, Sullivan L, Meigs JB. Metabolic syndrome as a precursor of cardiovascular disease and type 2 diabetes mellitus. Circulation. 2005;112:3066-3072.
8. Ervin RB. Prevalence of metabolic syndrome among adults 20 years of age and over, by sex, age, race and ethnicity, and body mass index: United States, 2003-2006. Natl Health Stat Report. 2009;13:1-7.
9. Cheung BM, Ong KL, Man YB, Wong LY, Lau CP, Lam KS. Prevalence of the metabolic syndrome in the United States National Health and Nutrition Examination Survey 1999-2002 according to different defining criteria. J Clin Hypertens (Greenwich). 2006;8:562-570.
10. Grundy SM, Brewer HB Jr, Cleeman JI, Smith SC Jr, Lenfant C; American Heart A, National Heart L and Blood I. Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation. 2004;109:433-438.
11. Pinto NM, Marino BS, Wernovsky G, de Ferranti SD, Walsh AZ, Laronde M, Hyland K, Dunn SO Jr, Cohen MS. Obesity is a common comorbidity in children with congenital and acquired heart disease. Pediatrics. 2007;120:e1157-e1164.
12. Moons P, Van Deyk K, Dedroog D, Troost E, Budts W. Prevalence of cardiovascular risk factors in adults with congenital heart disease. Eur J Cardiovasc Prev Rehabil. 2006;13:612-616.
13. Cohen MS. Clinical practice: the effect of obesity in children with congenital heart disease. Eur J Pediatr. 2012;171:1145-1150.
14. Stefan MA, Hopman WM, Smythe JF. Effect of activity restriction owing to heart disease on obesity. Arch Pediatr Adolesc Med. 2005;159:477-481.
15. Webb GD, Williams RG. 32nd Bethesda Conference: "care of the adult with congenital heart disease" 1. J Am Coll Cardiol. 2001;37:1162-1165.
16. Freud LR, Webster G, Costello JM, Tsao S, Rychlik K, Backer CL, Deal BJ. Growth and obesity among older single ventricle patients presenting for Fontan conversion. World J Pediatr Congenit Heart Surg. 2015;6:514-520.
17. Chung ST, Hong B, Patterson L, Petit CJ, Ham JN. High overweight and obesity in Fontan patients: a 20-year history. Pediatr Cardiol. 2015. doi: 10.1007/ s00246-015-1265-7 [Epub ahead of print].
18. Wellnitz K, Harris IS, Sapru A, Fineman JR, Radman M. Longitudinal development of obesity in the post-Fontan population. Eur J Clin Nutr. 2015;69:1105-1108.
19. Martinez-Quintana E, Rodriguez-Gonzalez F, Nieto-Lago V, Novoa FJ, Lopez-Rios L, Riano-Ruiz M. Serum glucose and lipid levels in adult congenital heart disease patients. Metabolism. 2010;59:1642-1648.
20. Ohuchi H, Miyamoto Y, Yamamoto M, Ishihara H, Takata H, Miyazaki A, Yamada O, Yagihara T. High prevalence of abnormal glucose metabolism in young adult patients with complex congenital heart disease. Am Heart J. 2009;158:30-39.
21. Pelliccia A, Zipes DP, Maron BJ. Bethesda Conference #36 and the European Society of Cardiology Consensus Recommendations revisited a comparison of U.S. and European criteria for eligibility and disqualification of competitive athletes with cardiovascular abnormalities. J Am Coll Cardiol. 2008;52:1990-1996.
22. Longmuir PE, Brothers JA, de Ferranti SD, Hayman LL, Van Hare GF, Matherne GP, Davis CK, Joy EA, McCrindle BW; American Heart Association Atherosclerosis H and Obesity in Youth Committee of the Council on Cardiovascular Disease in the Y. Promotion of physical activity for children and adults with congenital heart disease: a scientific statement from the American Heart Association. Circulation. 2013;127:2147-2159.
23. Diller GP, Dimopoulos K, Okonko D, Li W, Babu-Narayan SV, Broberg CS, Johansson B, Bouzas B, Mullen MJ, Poole-Wilson PA, Francis DP, Gatzoulis MA. Exercise intolerance in adult congenital heart disease: comparative severity, correlates, and prognostic implication. Circulation. 2005;112:828-835.
24. Reybrouck T, Mertens L. Physical performance and physical activity in grownup congenital heart disease. Eur J Cardiovasc Prev Rehabil. 2005;12:498-502.
25. Thompson PD, Buchner D, Pina IL, Balady GJ, Williams MA, Marcus BH, Berra K, Blair SN, Costa F, Franklin B, Fletcher GF, Gordon NF, Pate RR, Rodriguez BL, Yancey AK, Wenger NK; American Heart Association Council on Clinical Cardiology Subcommittee on Exercise R, Prevention, American Heart Association Council on Nutrition PA and Metabolism Subcommittee on Physical A. Exercise and physical activity in the prevention and treatment of atherosclerotic cardiovascular disease: a statement from the Council on Clinical Cardiology (Subcommittee on Exercise, Rehabilitation, and Prevention) and the Council on Nutrition, Physical Activity, and Metabolism (Subcommittee on Physical Activity). Circulation. 2003;107:3109-3116.
26. Owens JL, Musa N. Nutrition support after neonatal cardiac surgery. Nutr Clin Pract. 2009;24:242-249.
27. Weaver LT. Rapid growth in infancy: balancing the interests of the child. J Pediatr Gastroenterol Nutr. 2006;43:428-432.
28. Barker DJ, Osmond C, Forsen TJ, Kajantie E, Eriksson JG. Trajectories of growth among children who have coronary events as adults. N Engl J Med. 2005;353:1802-1809.
29. Vieira TC, Trigo M, Alonso RR, Ribeiro RH, Cardoso MR, Cardoso AC, Cardoso MA. Assessment of food intake in infants between 0 and 24 months with congenital heart disease. Arq Bras Cardiol. 2007;89:219-224.
30. Flegal KM, Carroll MD, Kit BK, Ogden CL. Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999-2010. JAMA. 2012;307:491-497.
31. Wang Y, Beydoun MA. The obesity epidemic in the United States-gender, age, socioeconomic, racial/ethnic, and geographic characteristics: a systematic review and meta-regression analysis. Epidemiol Rev. 2007;29:6-28.
32. Zaidi AN, Bauer JA, Michalsky MP, Olshove V, Boettner B, Phillips A, Cook SC. The impact of obesity on early postoperative outcomes in adults with congenital heart disease. Congenit Heart Dis. 2011;6:241-246.
33. Goff DC Jr, Lloyd-Jones DM, Bennett G, Coady S, D'Agostino RB Sr, Gibbons R, Greenland P, Lackland DT, Levy D, O'Donnell CJ, Robinson JG, Schwartz JS, Shero ST, Smith SC Jr, Sorlie P, Stone NJ, Wilson PW; American College of Cardiology/American Heart Association Task Force on Practice G. 2013 ACC/ AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2014;63:2935-2959.
34. Washington U. Obesity in Washington State.
35. Berenson GS, Srinivasan SR, Bao W, Newman WP III, Tracy RE, Wattigney WA. Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults. The Bogalusa Heart Study. N Engl J Med. 1998;338:1650-1656.
36. Expert Panel on Integrated Guidelines for Cardiovascular H, Risk Reduction in C, Adolescents, National Heart L and Blood I. Expert panel on integrated guidelines for cardiovascular health and risk reduction in children and adolescents: summary report. Pediatrics. 2011;128(suppl 5):S213-S256.